BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28302723)

  • 1. Identification and characterization of a missense mutation in the
    Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
    J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Selvan N; George S; Serajee FJ; Shaw M; Hobson L; Kalscheuer V; Prasad N; Levy SE; Taylor J; Aftimos S; Schwartz CE; Huq AM; Gecz J; Wells L
    J Biol Chem; 2018 Jul; 293(27):10810-10824. PubMed ID: 29769320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in
    Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
    J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
    [No Abstract]   [Full Text] [Related]  

  • 4. A missense mutation in the catalytic domain of O-GlcNAc transferase links perturbations in protein O-GlcNAcylation to X-linked intellectual disability.
    Pravata VM; Gundogdu M; Bartual SG; Ferenbach AT; Stavridis M; Õunap K; Pajusalu S; Žordania R; Wojcik MH; van Aalten DMF
    FEBS Lett; 2020 Feb; 594(4):717-727. PubMed ID: 31627256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
    Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
    Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe.
    Kositzke A; Fan D; Wang A; Li H; Worth M; Jiang J
    Int J Biol Macromol; 2021 Feb; 169():51-59. PubMed ID: 33333092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conserved threonine-rich region of the HCF-1
    Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W
    J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358
    [No Abstract]   [Full Text] [Related]  

  • 10. O-Linked N-Acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Interact with Mi2β Protein at the Aγ-Globin Promoter.
    Zhang Z; Costa FC; Tan EP; Bushue N; DiTacchio L; Costello CE; McComb ME; Whelan SA; Peterson KR; Slawson C
    J Biol Chem; 2016 Jul; 291(30):15628-40. PubMed ID: 27231347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast cells as an assay system for in vivo O-GlcNAc modification.
    Nakanishi H; Li F; Han B; Arai S; Gao XD
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of
    Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
    J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The O-GlcNAc Transferase Intellectual Disability Mutation L254F Distorts the TPR Helix.
    Gundogdu M; Llabrés S; Gorelik A; Ferenbach AT; Zachariae U; van Aalten DMF
    Cell Chem Biol; 2018 May; 25(5):513-518.e4. PubMed ID: 29606577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development.
    Webster DM; Teo CF; Sun Y; Wloga D; Gay S; Klonowski KD; Wells L; Dougan ST
    BMC Dev Biol; 2009 Apr; 9():28. PubMed ID: 19383152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.
    Stephen HM; Adams TM; Wells L
    Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
    Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
    J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel O-GlcNAc transferase substrates using yeast cells expressing OGT.
    Li F; Yang G; Tachikawa H; Shao K; Yang Y; Gao XD; Nakanishi H
    J Gen Appl Microbiol; 2021 Apr; 67(1):33-41. PubMed ID: 33229814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic prediction of putative conveyers of O-GlcNAc transferase intellectual disability.
    Mitchell CW; Czajewski I; van Aalten DMF
    J Biol Chem; 2022 Sep; 298(9):102276. PubMed ID: 35863433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
    Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
    J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.